Hosted on MSN9mon
Tempus wins FDA nod for AI-backed heart diagnosticRecently-IPO'ed health tech firm Tempus AI (NASDAQ:TEM) on Wednesday announced that the U.S. FDA cleared its Tempus ECG-AF device designed to leverage artificial intelligence to help detect ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results